Evaluation of Hemodynamics and Amount of Blood Flowing Through the Kidneys During Liver Transplant by Measuring Some Physiological Substances in Blood and Urines
- Conditions
- Hypovolemia During Liver TransplantationRenal Hypoperfusion During Liver Transplantation
- Registration Number
- NCT01650116
- Lead Sponsor
- Azienda Ospedaliera di Padova
- Brief Summary
The purpose of this study is to verify any existing relationship between urinary parameters (such as excretion of sodium, chlorine, urinary partial CO2 pressure \[PuCO2\]) and general volemic indicators (such as PiCCO, ScvO2, O2 delivery) during liver transplant.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
- surgery for liver transplantation
- age 18-75
- ASA class I-III
Exclusion Criteria
- age above 75 or under 18
- ASA class IV
- pre-existing renal failure
- pregnant patients
- patients unable to give written consent
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Determination of hemodynamic indicators (PiCCO, ScvO2, O2-delivery) and three urinary analytes (sodium, chloride, CO2 partial pressure) During the stay of the patient in the operating room (in average 8 hours) and the subsequent stay in the post-surgery intensive care unit (in average 5 days)
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link sodium and chlorine excretion to renal perfusion during liver transplants?
How does urinary partial CO2 pressure compare to PiCCO and ScvO2 in assessing volemic status during liver transplantation?
Are there specific biomarkers that predict renal hypoperfusion risk in patients undergoing liver transplants?
What adverse events are associated with hypovolemia management strategies during liver transplantation procedures?
What alternative renal perfusion monitoring techniques are being explored alongside urinary biomarkers in liver transplant settings?
Trial Locations
- Locations (1)
Azienda Ospedaliera di Padova
🇮🇹Padova, Italy
Azienda Ospedaliera di Padova🇮🇹Padova, ItalyPaolo Feltracco, M.D.Principal InvestigatorAndrea Bortolato, M.D.Principal InvestigatorDaniele Bonvicini, M.D.Sub InvestigatorTommaso Tonetti, M.D.Sub Investigator